Cancer and Its Management. (Record no. 41773)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 11374nam a22005893i 4500 |
001 - CONTROL NUMBER | |
control field | EBC1813087 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729123117.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2014 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781118468708 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9781118468739 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC1813087 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL1813087 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10952044 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaONFJC)MIL650888 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)893332546 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC270.8.S68 2015 |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.994 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tobias, Jeffrey S. |
245 10 - TITLE STATEMENT | |
Title | Cancer and Its Management. |
250 ## - EDITION STATEMENT | |
Edition statement | 7th ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Newark : |
Name of producer, publisher, distributor, manufacturer | John Wiley & Sons, Incorporated, |
Date of production, publication, distribution, manufacture, or copyright notice | 2014. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2015. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (627 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Cover -- Title Page -- Copyright -- Contents -- Preface -- Acknowedgements -- Abbreviations -- Chapter 1 The modern management of cancer: an introductory note -- References -- Further reading -- Chapter 2 Epidemiology, cure, treatment trials and screening -- Terminology and methods in epidemiology -- Geographical distribution of cancer -- Temporal distribution of cancer -- Causes of cancer suggested by epidemiological studies -- Inhaled carcinogens -- Lifestyle and diet -- Ionizing irradiation -- Occupational factors -- Viral causes -- Cancer statistics -- Survival data and determination of cure in cancer -- Assessment of results: trials of treatment -- Randomized trials -- Informed consent -- Non-randomized studies of treatment -- Screening for cancer -- Secondary prevention of cancer -- References -- Further reading -- Chapter 3 Biology of cancer -- Carcinogenesis: persistent genetic damage -- Chemical carcinogens -- Ionizing and ultraviolet irradiation -- Initiators and promoters in carcinogenesis -- Repair of damage to DNA induced by carcinogens -- Inherited defects involving DNA damage or repair processes that predispose to cancer -- Viral causes of cancer -- RNA viruses -- DNA viruses -- Cellular oncogenes -- Tumour-suppressor genetic mechanisms in cancer development -- Cell division -- Inheritance of cancer -- Clonal origin, progression and growth of a cancer -- Monoclonality and heterogeneity in cancer -- The growth of cancer -- Differentiation in cancer -- Invasion, angiogenesis and metastasis -- Tumour immunology -- Immune responses to cancer -- Monoclonal antibodies -- Reference -- Further reading -- Chapter 4 Staging of tumours -- Staging notation -- The primary tumour (T) -- Lymph node involvement (N) -- Presence of metastases (M) -- Staging techniques -- Ultrasound -- Computed tomography -- Magnetic resonance imaging. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Isotope scanning -- Positron emission tomography -- Diagnosis of specific metastatic sites -- Pulmonary metastases -- Bone metastases -- Hepatic metastases -- Brain metastases -- The role of surgery in diagnosis and staging -- Tumour markers -- Human chorionic gonadotrophin -- α-Fetoprotein -- Placental alkaline phosphatase -- Carcinoembryonic antigen -- CA-125 -- CA-19-9 -- Molecular staging of cancer -- References -- Further reading -- Chapter 5 Radiotherapy -- Sources and production of ionizing radiation -- Radioactive isotopes -- Artificial production of X-rays and particles -- Biological properties of ionizing radiation -- Tumour sensitivity -- Fractionation and cell death -- Response of biological tissues to radiation -- Normal tissues -- Highly radiosensitive tissues -- Moderately radiosensitive tissues -- Less radiosensitive tissues -- Late sequelae of radiation -- Carcinogenesis -- Teratogenicity -- Mutagenicity -- Technical aspects of radiotherapy -- Radiotherapy planning and treatment techniques -- Treatment prescription -- Maximum, minimum and modal dose -- Open (direct) and wedged fields -- Parallel opposed fields -- Shrinking field technique -- Systemic irradiation -- Immobilization devices -- Conformal and intensity-modulated radiation therapy -- Integration of radiotherapy and chemotherapy -- Proton therapy -- References -- Further reading -- Chapter 6 Systemic treatment for cancer -- Chemotherapy -- The cellular targets for anticancer drugs -- The development of an anticancer drug -- Principles of cancer chemotherapy -- The cell cycle -- Resistance to cancer chemotherapy -- Predicting sensitivity to anticancer drugs -- What cancer chemotherapy has achieved -- Classes of cytotoxic drugs, mode of action and toxicity -- Targeted therapy for cancer -- Hypersensitivity reactions -- The administration of cytotoxic agents. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Chemotherapy-induced vomiting -- Long-term complications of cancer chemotherapy -- Principles of hormone therapy -- Steroid hormone receptors -- Hormone receptor assays -- Approaches to hormone therapy -- Cytokines in cancer treatment -- Interferons -- Interleukins -- Monoclonal antibodies in cancer therapy -- Gene therapy -- Immunotherapy -- References -- Chapter 7 Supportive care and symptom relief -- Talking about the diagnosis and treatment -- Support, counselling and rehabilitation -- Stoma care -- Breast prostheses -- Laryngectomy rehabilitation -- Limb prostheses -- Other prostheses -- Home support -- National counselling organizations -- Cancer treatment and the quality of life -- Symptom control [3,4] -- Pain -- Anorexia and nausea [10] -- Oral mucositis -- Constipation -- Intestinal obstruction -- Depression and anxiety -- The care of the dying -- Terminal care: home, hospice and support teams -- Cancer quackery -- References -- Further reading -- Chapter 8 Medical problems and radiotherapy emergencies -- Bone marrow failure and its consequences -- The management of marrow depression by blood component therapy -- Haemopoietic growth factors [3] -- Clinical use of haemopoietic growth factors -- Infections in the immunocompromised patient -- Bacteraemia and septicaemia -- Respiratory infection -- Urinary tract infections -- Gastrointestinal infections -- Meningitis -- Skin infections -- Prevention of infection in the leucopenic patient -- Cancer cachexia and the nutritional support of the cancer patient -- Pathogenesis of malnutrition in cancer -- Maintaining nutrition -- Acute metabolic disturbances -- Hypercalcaemia -- Tumour lysis syndrome -- Serous effusions -- Pleural effusion [17] -- Pericardial effusion -- Ascites -- Carcinomatous meningitis -- Progressive multifocal leucoencephalopathy -- Management of hepatic metastases. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Pharmacological -- Radiotherapeutic (and radiofrequency) ablation -- Surgical -- Radiotherapeutic emergencies -- Acute spinal cord or cauda equina compression -- Superior vena caval obstruction -- Other radiotherapy emergencies -- Cancer during pregnancy -- References -- Further reading -- Chapter 9 Paraneoplastic syndromes -- Fever due to malignant disease -- Ectopic hormone production in cancer -- Syndrome of inappropriate antidiuretic hormone secretion -- Ectopic adrenocorticotrophic hormone production -- Hypoglycaemia -- Gynaecomastia and gonadotrophin production -- Other ectopic hormones -- Haematological syndromes -- Anaemia -- Erythrocytosis -- Thrombotic disorders -- Disseminated intravascular coagulation -- Neurological syndromes -- Encephalomyelitis -- Cerebellar degeneration -- Carcinomatous myelopathy -- Peripheral neuropathy -- Lambert-Eaton myasthenic syndrome -- Muscle and joint syndromes -- Polymyositis and dermatomyositis -- Hypertrophic pulmonary osteoarthropathy -- Polyarthritis -- Dermatological syndromes -- Acanthosis nigricans -- Hypertrichosis (lanuginosa acquisita) -- Erythroderma -- Vasculitis -- Pyoderma gangrenosum -- Bullous eruptions -- Ichthyosis -- Alopecia -- Generalized pruritus -- Nephrotic syndrome -- References -- Chapter 10 Cancer of the head and neck -- Introduction, aetiology and epidemiology -- Pathology -- Clinical staging -- Distant metastasis -- Investigation -- Carcinoma of the larynx -- Management and prognosis -- Conservative surgery in laryngeal cancer -- Rehabilitation -- Carcinoma of the pharynx -- Anatomy and patterns of metastasis -- Carcinoma of the nasopharynx -- Carcinoma of the oropharynx -- Lymphoma of the pharynx -- Carcinoma of the laryngopharynx (hypopharynx) -- Tumours of the oral cavity -- Management -- Carcinoma of the lip -- Treatment -- Nasal cavity and paranasal sinuses. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Tumours of the middle ear -- Carcinoma of the pinna and external auditory canal -- Chemotherapy in squamous carcinomas of the head and neck -- Tumours of salivary glands -- Clinical features and management -- Prognosis -- Tumours of the orbit and eye [59,60] -- Orbit -- Tumours of the eyelid and conjunctiva -- Tumours of the globe -- References -- Further reading -- Chapter 11 Brain and spinal cord -- Brain tumours -- Cellular biology of brain tumours -- Pathological classification of brain tumours -- Clinical features -- Management of brain tumours -- Treatment on relapse -- Prognosis of brain tumours -- Secondary deposits in the brain -- Tumours of the spinal cord [65,66] -- Symptoms -- Differential diagnosis -- Investigation -- Management -- Tumours of the peripheral nerves -- Radiation damage in the brain and spinal cord -- References -- Further reading -- Chapter 12 Tumours of the lung and mediastinum -- Carcinoma of the bronchus -- Introduction, aetiology and epidemiology -- The molecular pathology of lung cancer -- Pathology of lung cancer -- Patterns of local invasion and metastasis -- Clinical features -- Staging notation -- Investigation and staging -- Treatment -- Prognosis of lung cancer: geographical variation of lung cancer mortality rates -- Tumours of the mediastinum -- Anterosuperior mediastinum -- Middle mediastinum -- Posterior mediastinum -- Mesothelioma -- Pathology -- Clinical features -- Diagnosis -- Treatment -- Primary tracheal tumours -- References -- Further reading -- Chapter 13 Breast cancer -- Incidence, aetiology and epidemiology -- Pathology and mode of spread -- Clinical features -- Confirming the diagnosis -- Preoperative investigation -- Staging notation -- Hormone receptors in breast cancer -- Screening for breast cancer -- Management of the primary tumour in 'early' breast cancer. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Combinations of surgery and radiotherapy [39-41]. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Treatment. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Diagnosis. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms--therapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms--diagnosis. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Traitement. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Diagnostic. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Diagnosis. (OCoLC)fst00845345. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer--Treatment. (OCoLC)fst00845538. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hochhauser, Daniel. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Tobias, Jeffrey S. |
Title | Cancer and Its Management |
Place, publisher, and date of publication | Newark : John Wiley & Sons, Incorporated,c2014 |
International Standard Book Number | 9781118468739 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1813087">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1813087</a> |
Public note | Click to View |
No items available.